Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This anesthetic regimen consists of a low-dose combination of propofol, fentanyl, and sevoflurane, titrated to maintain a shallow depth of anesthesia as measured by a Bispectral Index (BIS) value above 45. Developed and studied by Heidelberg University, this specific protocol was evaluated in patients undergoing shoulder surgery to investigate the impact of anesthesia depth on cellular activity (T-cells, NK-cells, monocytes) and protein expression patterns in the cerebrospinal fluid and blood. The study aimed to determine if maintaining a lighter plane of anesthesia could mitigate certain physiological or immunological changes compared to deeper anesthetic states (BIS ≤ 45).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on propofol + fentanyl + sevoflurane (Heidelberg University).